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Introduction
This is the second of an unplanned series of articles about
the doubts that arise when young doctors have to care for
medical experts. The availability and quality of evidence
that medical experts have built up may not help novice
doctors in friendly clinical decision-making (i.e., whether a
treatment will do more good than harm). In the first article
we analysed the case of Emeritus Professor Crow, an
intermediate-risk patient for pulmonary embolism in whom
the benefit of thrombolysis was disputable [1]. Today we
face another difficult decision: whether magnetic resonance
imaging (MRI) is preferable to computed tomography (CT)
for diagnosing acute stroke.
You are the physician on duty at the emergency
department (ED), when Professor Peacock, a 71-year-old
professor of neurology, enters with a right hemiplegia [2].
While starting to collect clinical data and ordering studies,
you remember that, five years ago, you attended Prof.
Peacock’s speech at the National Stroke Conference. As he
is supposed to be a field expert in stroke management, you
feel under pressure. You would like to engage Prof.
Peacock in every phase of diagnosis and treatment: the
physician-patient is well-informed, and his decision may
follow different strategies from less-informed patients [3].
Then too, you are well aware that, to disseminate their
opinions and dominance, experts commonly disagree with
young doctors, so it would be wise to listen to his advice.
Unfortunately, he is aphasic.
As his wife reports, he started complaining about
walking and other motor disorders about an hour prior to
admission. There is still time for thrombolysis, if there are
no contraindications. The resident on duty, who recently
attended a course on neuroimaging, recalls that MRI is
excellent for identifying ischemic brain lesions. ‘We
should offer him the most recent and innovative manage-
ment’, the resident is convinced. ‘I’ve never requested an
MRI for a suspected acute stroke’ you reply in a low voice,
adding ‘What if there is a brain haemorrhage? Are you sure
MRI is sufficiently sensitive in identifying cerebral bleed-
ing?’‘No data were presented, only opinions’ the resident
whispers. Despite the low voice, Prof. Peacock’s wife
understands the doubt we are facing. She confidently pre-
sents a conclusion based on implicit values about the best:
‘He needs a cerebral MRI’ cutting off any further discus-
sion for a moment.
You are astonished. ‘Am I acting like a stubborn old
physician refusing to utilise new technologies, or are the
experts blindly trusting that new technologies can only be
beneficial?’ Before calling the stroke experts on duty, you
decide to take a quiet look at the Cochrane Library. The
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title seems fitting: ‘Magnetic resonance imaging vs. com-
puted tomography for detection of acute vascular lesions in
patients presenting with stroke symptoms’ [4]. You open
the systematic review on the computer screen.
The Cochrane point of view: a systematic review
The authors did this review to compare the diagnostic
accuracy of cerebral diffusion-weighted (DWI) MRI or CT
in detecting ischemic lesions caused by acute ischemic
stroke, and to estimate the diagnostic accuracy of MRI for
acute haemorrhagic stroke [4]. Eight studies with a total of
308 participants were identified. Seven studies were used
for the assessment of ischemic stroke, and two for haem-
orrhagic stroke. In all the studies, the spectrum of patients
was relatively narrow, the samples were small, there was
substantial incorporation bias (i.e., when the MRI test
under consideration is used to determine the reference
standard, or the reference standard is used to determine the
results of the diagnostic test) [5], and blinding procedures
for outcome assessors were often incomplete.
In patients with an acute ischemic stroke, the summary
estimates for DWI MRI are: sensitivity 0.99 (95% CI
0.23–1.00) and specificity 0.92 (95% CI 0.83–0.97) [4].
You feel the sensitivity is high but the confidence interval
is wide and includes values that are far from optimal. The
summary estimates for CT are: sensitivity 0.39 (95% CI
0.16–0.69) and specificity 1.00 (95% CI 0.94–1.00) [4].
The specificity is excellent, and the confidence interval is
narrow.
The two studies on haemorrhagic stroke report high
estimates for DWI and gradient-echo sequences, but have
inconsistent reference standards. The authors did not cal-
culate overall estimates for these two studies, and were not
able to assess how practical or cost-effective they were [4].
They speculate that DWI MRI appeared to be more sen-
sitive than CT for the early detection of ischemic stroke in
highly selected patients [4]. Is this conclusion a matter for
an emergency physician? The characteristics of the patient
population were not a representative of the typical popu-
lation being assessed for thrombolysis. First, all but one
study included a very narrow spectrum of patients with
typical anterior circulation stroke and limited severity.
Moreover, the study with a wider spectrum of patients still
only included mostly mild strokes (median National Insti-
tutes of Health Stroke Scale [NIHSS = 3], scale ranges
from 0 to 42, maximal severity) [6]. Patients with severe
stroke who often do not tolerate MRI were not eligible [6].
Second, the information on other patients who were
excluded because they either could not tolerate MRI or had
contraindications (e.g., pacemakers and metal implants),
was provided in only three studies [4]. About 11% of the
patients initially screened for inclusion were subsequently
excluded in the largest study [6]. Third, in most studies,
patients with stroke mimicking diseases (for example
cerebral neoplasms or systemic infections) were also not
included in the spectrum of interest [4]. The sample was in
fact a poor representative of the acute patients typically
seen in an ED, where 15–30% with an initial clinical
diagnosis of stroke are ultimately found to have stroke-
mimicking pathologies. All these limitations make it dif-
ficult to translate the estimates of accuracy provided by the
meta-analyses to routine clinical practice [4]. In fact, the
review authors conclude ‘In particular, further studies are
needed to provide clear evidence that MRI can be used as
the imaging modality of first choice for patients with sus-
pected acute stroke in routine practice, and that patients
without evidence of acute intracerebral haemorrhage on
MRI really do not have acute intracranial bleeding, and
hence can be safely considered for thrombolytic treat-
ments’ [4].
The stroke expert’s point of view: clinical guidelines
The four most recent guidelines are provided by the
Therapeutics and Technology Assessment Subcommittee
of the American Academy of Neurology, by the National
Institute for Clinical Excellence (NICE), by the Italian
SPREAD Group and the Scottish Intercollegiate Guidelines
Network (SIGN) [7–10]. The first guideline is rather vague
in suggesting which test should be preferred (assuming
there is one): instead of pointing out where evidence is
lacking or inadequate, guideline authors speculate ‘above’
the evidence. In particular, panellists state: ‘DWI MRI is
established as useful, and should be considered more useful
than non-contrast CT for the diagnosis of acute ischemic
stroke within 12 h of symptom onset. DWI MRI should be
performed for the most accurate diagnosis of acute ische-
mic stroke; however, the sensitivity of DWI MRI for the
diagnosis of ischemic stroke in a general sample of patients
with possible acute stroke is not perfect. There is insuffi-
cient evidence to support or refute the value of perfusion
weighted imaging (PWI) in diagnosing acute ischemic
stroke’ [7]. But, most importantly, they write: ‘The diag-
nostic accuracy of DWI MRI in evaluating cerebral
haemorrhage is outside the scope of this guideline’ [7]. For
urgent brain imaging, the recommendation promoted by the
NICE supports DWI MRI [8].Conversely, the SPREAD
group firmly states ‘Cerebral CT without contrast is sug-
gested as soon as possible at the ED to differentiate stroke
from stroke-mimicking pathologies, and haemorrhagic
stroke from ischemic stroke; and to identify early signs of
cerebral ischemia’ [9]. SIGN’s recommendation similarly




Waiting for the stroke expert, you decide that a cerebral CT
should be the first choice. You approach Prof. Peacock’s
wife to deal with her anxieties, and tell her, first, what her
husband might have, and second, what not to expect from
an MRI, and what to expect from a CT scan. A small
subdural haemorrhage is detected in the right temporal
area. There are no signs of ischemia.
A few minutes later, the neurologist from the stroke
team arrives. ‘My husband urgently needs your help!’ The
specialist carefully examines Prof. Peacock. After viewing
the clinical record and cerebral CT, he prints thrombolysis
inclusion and exclusion criteria (see Table 1) [11]. He
invites Prof. Peacock’s wife to sit down, and starts kindly
to explain: ‘Let me tell you about the possible risks and
benefits of thrombolysis …’.
Professor Peacock has been lucky despite the limited
directness of the evidence, its low quality and the presence
of a young doctor. All these elements could interfere with
the clinical decision-making, giving precedence to the
diagnostic test that might have led to a treatment that
would do more harm than good.
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Table 1 Main inclusion and exclusion criteria for thrombolysis in patients with acute ischemic stroke. [11]
Inclusion criteria Exclusion criteria
Age C18 years Minor or rapidly improving symptoms or signs
Clinical diagnosis of stroke with clinically
meaningful neurologic deficit
CT signs of intracranial haemorrhage
Clearly defined time of onset before treatment History of intracranial haemorrhage or symptoms of subarachnoid haemorrhage
Baseline CT showing no evidence of intracranial
haemorrhage
Seizure at stroke onset
Stroke or serious head injury within 3 months
Recent history of major surgery, serious trauma, or gastrointestinal or urinary tract
haemorrhage
Systolic BP [185 mmHg/diastolic BP [110 mmHg; glucose \50 mg/dL or [400 mg/dL
Heparin therapy within 48 h associated with elevated activated partial thromboplastin time;
anticoagulation due to oral anticoagulants (international normalized ratio [INR [ 1.7])
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